Neurogan Health | GHK-Cu Nasal Spray 50mg | 10ml

Neurogan GHK-Cu Nasal Spray presents copper tripeptide inside a minimalist, needle-free intranasal wellness format. Interest in GHK-Cu has expanded from topical skincare and laboratory research into broader healthy-aging routines, although evidence depends strongly on the delivery route and product formulation. Each bottle is labelled with 50 mg total GHK-Cu, providing 625 mcg per metered spray across approximately 80 sprays. The formula is intended for adults seeking a research-informed beauty and wellness routine, but it is not an approved drug and should not be described as healing tissue, reversing aging, improving cognition or treating a medical condition.

The Science of Neurogan GHK-Cu Nasal Spray Optimization

GHK-Cu is a coordination complex formed when the tripeptide Gly-His-Lys binds copper. Its biochemical properties have been investigated in cellular, tissue and animal models, while human evidence for intranasal use remains insufficient for establishing clinical benefits, pharmacokinetics or long-term safety.

Copper-Tripeptide Identity: GHK-Cu combines three amino acids with a copper ion. Laboratory research has examined the complex in relation to extracellular-matrix signaling, oxidative balance and cellular-response pathways, but these mechanisms do not establish outcomes from this finished nasal product.

Intranasal Delivery Context: The nasal format is designed to place a measured mist onto the nasal mucosa without injection. A product-specific human absorption study was not identified, so claims of complete absorption, superior bioavailability or systemic tissue delivery should be treated as manufacturer positioning rather than proven performance.

Measured Formula and Batch Review: The product facts panel lists 50 mg total and 625 mcg per spray. Neurogan publishes batch testing, but the received bottle and lot-specific COA should be checked because analytical results may vary between batches.

Review the published preclinical study of intranasal GHK-Cu in an aging mouse model.

Key Benefits of Neurogan GHK-Cu Nasal Spray

Specifications

Usage Guide

Follow the directions printed on the received bottle. The current website text states one to two sprays daily, providing 625–1,250 mcg total. Use on a clean, dry nose, place only the tip of the nozzle just inside the nostril, keep the bottle level and avoid aiming directly upward toward the sinuses. Spray gently and inhale slowly. Do not increase the amount in an attempt to accelerate results. Because one promotional image shows a different morning-and-evening pattern, the physical bottle label or direct written guidance from Neurogan should take priority. Do not share the applicator, and keep the nozzle clean and capped.

Safety Information

This product is not an FDA-approved drug or medication and should not be used to diagnose, treat, cure or prevent disease. It is restricted by the brand to adults aged 18 and over and should not be used during pregnancy or breastfeeding. Consult a physician before use, particularly with Wilson disease, another copper-metabolism disorder, significant liver or kidney disease, regular medication use or a history of reactions to intranasal products. Human safety and absorption data for intranasal GHK-Cu remain limited. Discontinue use if persistent burning, nasal irritation, bleeding, swelling, breathing difficulty or another concerning reaction occurs. FDA’s published GHK-Cu concern applies specifically to compounded injectable products, not this nasal spray, but highlights limited human safety data and peptide-quality considerations.

Review FDA information about safety considerations for compounded injectable GHK-Cu.

Frequently Asked Questions